Causeway Therapeutics

Developer of microRNA-based therapies for tendinopathy, cardiovascular diseases, and skin aging

placeGlasgow, Scotland, United Kingdom calendar_todayFounded 2017 groups9 employees language causewaytx.com

Registered entities

Investor mix

4 investors on record; lead investors include University of Glasgow, Scottish Enterprise, Mediqventures.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon